{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:57:51Z","timestamp":1790233071798,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.amjcard.2006.11.022","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T14:30:22Z","timestamp":1164897022000},"page":"S47-S55","source":"Crossref","is-referenced-by-count":82,"special_numbering":"S1","title":["Safety Considerations with Gastrointestinally Active Lipid-Lowering Drugs"],"prefix":"10.1016","volume":"99","author":[{"given":"Terry A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Armani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"McKenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Guyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.11.022_bib1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0002-9149(02)02798-4","article-title":"Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia","volume":"90","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2006.11.022_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2004.02.059","article-title":"Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals","volume":"93","author":"Feldman","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1185\/030079904125003872","article-title":"Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin","volume":"20","author":"Kosoglou","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2006.11.022_bib5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2004.02.060","article-title":"Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia","volume":"93","author":"Ballantyne","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib6","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.11.022_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1368-5031.2004.00289.x","article-title":"Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia","volume":"58","author":"Davidson","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amjcard.2006.11.022_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(02)03236-8","article-title":"Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia","volume":"91","author":"Kerzner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0195-668X(02)00803-5","article-title":"Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"24","author":"Melani","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2006.11.022_bib10","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ahj.2004.03.052","article-title":"Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin","volume":"148","author":"Stein","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2006.11.022_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ahj.2004.11.023","article-title":"Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study","volume":"149","author":"Ballantyne","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2006.11.022_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4065\/79.5.620","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial","volume":"79","author":"Goldberg","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2006.11.022_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.clinthera.2004.11.016","volume":"26","author":"Bays","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2006.11.022_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.ajkd.2005.11.018","article-title":"The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD","volume":"47","author":"Landray","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2006.11.022_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2005.08.038","article-title":"Striated muscle safety of ezetimibe\/simvastatin (Vytorin)","volume":"97","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.11.022_bib18","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-140-8-200404200-00034","article-title":"Ezetimibe and statin-associated myopathy","volume":"140","author":"Fux","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-141-8-200410190-00021","article-title":"Ezetimibe and statin-associated myopathy [letter]","volume":"141","author":"Phillips","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amjmed.2005.06.051","article-title":"Monotherapy with ezetimibe causing myopathy","volume":"119","author":"Havranek","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/qjmed\/hci074","article-title":"Worsening myopathy associated with ezetimibe in a patient with McArdle disease","volume":"98","author":"Perez-Calvo","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.amjcard.2006.11.022_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0828-282X(06)70253-7","article-title":"Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"22","author":"Simard","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1126\/science.6587566","article-title":"High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle\u2019s syndrome to chromosome 11","volume":"225","author":"Lebo","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.amjcard.2006.11.022_bib25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1124\/jpet.301.3.1042","article-title":"Mechanistic studies on metabolic interactions between gemfibrozil and statins","volume":"301","author":"Prueksaritanont","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.11.022_bib26","first-page":"13A","article-title":"The pharmacokinetics of ezetimibe","volume":"10","author":"Simard","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.32.3.314","article-title":"Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia)","volume":"32","author":"Ghosal","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.amjcard.2006.11.022_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/dmd.30.5.505","article-title":"Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization","volume":"30","author":"Prueksaritanont","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.amjcard.2006.11.022_bib29","unstructured":"Zetia [ezetimibe]. In: Mosby\u2032s Drug Consult [database online]. 16th ed. Philadelphia: Elsevier; 2006."},{"key":"10.1016\/j.amjcard.2006.11.022_bib30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1001\/archinte.159.16.1893","article-title":"Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects","volume":"159","author":"Davidson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.11.022_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0026-0495(83)90113-0","article-title":"Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: colestipol and clofibrate","volume":"32","author":"Probstfield","year":"1983","journal-title":"Metabolism"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.11.022_bib33","doi-asserted-by":"crossref","first-page":"15E","DOI":"10.1016\/S0002-9149(00)00946-2","article-title":"Defining patient risks from expanded preventive therapies","volume":"85","author":"Tolman","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results","volume":"151","author":"Bradford","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib35","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(02)02356-1","article-title":"Side effects of statins: hepatitis versus \u201ctransaminitis\u201d\u2014myositis versus \u201cCPKitis\u201d","volume":"89","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib37","unstructured":"Vytorin [ezetimibe\/simvastatin]. In: Mosby\u2032s Drug Consult [database online]. 16th ed. Philadelphia: Elsevier; 2006."},{"key":"10.1016\/j.amjcard.2006.11.022_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.11.022_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1542\/peds.59.4.626","article-title":"Cholestyramine therapy and intestinal obstruction in infants","volume":"59","author":"Lloyd-Still","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.amjcard.2006.11.022_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2214\/ajr.134.4.827","article-title":"Intestinal obstruction associated with cholestyramine therapy","volume":"134","author":"Merten","year":"1980","journal-title":"AJR"},{"key":"10.1016\/j.amjcard.2006.11.022_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3476(96)70188-9","article-title":"Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia","volume":"129","author":"Tonstad","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.amjcard.2006.11.022_bib42","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1517\/13543784.9.11.2663","article-title":"Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent","volume":"9","author":"Davidson","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.amjcard.2006.11.022_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.amjcard.2005.11.039","article-title":"Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia","volume":"97","author":"Bays","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0021-9150(94)05418-I","article-title":"The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients","volume":"112","author":"Insull","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2006.11.022_bib45","unstructured":"Colestid (micronized colestipol hydrochloride tablets) [prescribing information]. Pfizer Inc Website. New York, NY: Pharmacia & Upjohn Inc. Available at: http:\/\/www.pfizer.com\/pfizer\/download\/uspi_colestid.pdf . Accessed July 15, 2006."},{"key":"10.1016\/j.amjcard.2006.11.022_bib46","unstructured":"Questran (cholestyramine) [advanced consumer information]. RxList Website. Princeton, NJ: Bristol Myers Squibb Inc. Available at: http:\/\/www.rxlist.com\/cgi\/generic3\/cholestyramine.htm . Accessed July 21, 2006."},{"key":"10.1016\/j.amjcard.2006.11.022_bib47","unstructured":"Welchol tablets (colesevelam hydorchloride) [prescribing information]. Parsippany, NJ: Sankyo Pharma Inc. Available at: http:\/\/www.welchol.com\/pdfs\/fullPI.pdf . Accessed July 20, 2006."},{"key":"10.1016\/j.amjcard.2006.11.022_bib48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.10263","article-title":"Colesevelam hydrochloride: a novel bile acid-binding resin","volume":"35","author":"Aldridge","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2006.11.022_bib49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1023\/A:1007831418308","article-title":"Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent","volume":"14","author":"Donovan","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2006.11.022_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2165\/00003088-200443130-00006","article-title":"Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics","volume":"43","author":"Jones","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjcard.2006.11.022_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(01)00437-3","article-title":"Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively","volume":"158","author":"Hunninghake","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2006.11.022_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9343(01)00638-6","article-title":"Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia","volume":"110","author":"Knapp","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2006.11.022_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/clc.4960240610","article-title":"Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia","volume":"24","author":"Davidson","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2006.11.022_bib54","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1185\/030079905X59157","article-title":"Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia","volume":"21","author":"McKenney","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2006.11.022_bib55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.mjt.0000155109.69831.a3","article-title":"Colesevelam HCl and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia","volume":"12","author":"Zema","year":"2005","journal-title":"Am J Ther"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906022405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906022405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T21:31:27Z","timestamp":1683667887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906022405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0002914906022405"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.11.022","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}